Amyvid FDA Approval History
FDA Approved: Yes (First approved April 6, 2012)
Brand name: Amyvid
Generic name: florbetapir F 18
Dosage form: Injection
Company: Eli Lilly and Company and Avid Radiopharmaceuticals, Inc.
Treatment for: Diagnosis and Investigation
Amyvid (florbetapir F 18) is a radioactive diagnostic agent used for brain imaging of beta-amyloid plaques in patients who are being evaluated for Alzheimer's Disease and other causes of cognitive decline.
Development timeline for Amyvid
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
